45 research outputs found

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    Crown depth and susceptibility to crown rot in wheat

    No full text
    Sources of partial resistance to crown rot caused by Fusarium pseudograminearum are detected in mature plants grown in artificially inoculated soil in the field. The resistance in most but not all of these sources can also be detected in seedlings. In order to determine whether partial resistance is related to depth of crown formation, this character was measured in 13 cultivars/lines with a range of reaction to crown rot. It was also measured in doubled haploid plants from the cross, Batavia/2–49. Crown depths varied from 17.1 mm to -2.3 mm (above ground) in pots in a waterbath at 25 °C and from 43.5 mm to 20.7 mm when plants were grown in the field. The correlation coefficient between relative susceptibility to crown rot (Field test) and crown depth of 13 cultivars/lines was 0.57 (p ≀ 0.05). With the exception of the cultivars, Sunco and Pelsart, partial resistance to crown rot was inversely related to depth of crown formation. This indicates that depth of crown formation may be partly responsible for the reaction of a cultivar/line to crown rot. Depth of crown formation was also measured in susceptible and partially resistant cultivars/lines grown from seed planted at different depths. As depth of seeding increased, depth of crown formation in partially resistant and susceptible cultivars/lines increased in similar proportions

    Registration of ‘Thunder CL’ Wheat

    No full text

    A Microsatellite Marker for Tagging Dn2

    No full text
    corecore